QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
NASDAQ:HOOK

Hookipa Pharma (HOOK) Competitors

$1.16
+0.03 (+2.65%)
(As of 06/5/2023 ET)
Compare
Today's Range
$1.08
$1.22
50-Day Range
$0.71
$1.97
52-Week Range
$0.68
$2.05
Volume
1.34 million shs
Average Volume
722,658 shs
Market Capitalization
$63.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50

HOOK vs. IMUX, VLON, APLT, IPA, RZLT, SYRS, DMAC, CLNN, BLPH, and SLGL

Should you be buying Hookipa Pharma stock or one of its competitors? The main competitors of Hookipa Pharma include Immunic (IMUX), Vallon Pharmaceuticals (VLON), Applied Therapeutics (APLT), ImmunoPrecise Antibodies (IPA), Rezolute (RZLT), Syros Pharmaceuticals (SYRS), DiaMedica Therapeutics (DMAC), Clene (CLNN), Bellerophon Therapeutics (BLPH), and Sol-Gel Technologies (SLGL). These companies are all part of the "pharmaceutical preparations" industry.

Hookipa Pharma vs.

Hookipa Pharma (NASDAQ:HOOK) and Immunic (NASDAQ:IMUX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, community ranking, media sentiment and profitability.

Hookipa Pharma has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, Immunic has a beta of 1.87, meaning that its share price is 87% more volatile than the S&P 500.

Hookipa Pharma has higher revenue and earnings than Immunic. Hookipa Pharma is trading at a lower price-to-earnings ratio than Immunic, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hookipa Pharma$14.25 million4.59-$64.92 million-$0.92-1.30
ImmunicN/AN/A-$120.41 million-$3.62-0.45

Immunic has a net margin of 0.00% compared to Hookipa Pharma's net margin of -416.94%. Hookipa Pharma's return on equity of -61.79% beat Immunic's return on equity.

Company Net Margins Return on Equity Return on Assets
Hookipa Pharma -416.94% -61.79% -40.55%
Immunic N/A -113.12% -100.63%

52.3% of Hookipa Pharma shares are owned by institutional investors. Comparatively, 60.7% of Immunic shares are owned by institutional investors. 4.6% of Hookipa Pharma shares are owned by company insiders. Comparatively, 5.0% of Immunic shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Immunic received 12 more outperform votes than Hookipa Pharma when rated by MarketBeat users. Likewise, 68.18% of users gave Immunic an outperform vote while only 67.83% of users gave Hookipa Pharma an outperform vote.

CompanyUnderperformOutperform
Hookipa PharmaOutperform Votes
78
67.83%
Underperform Votes
37
32.17%
ImmunicOutperform Votes
90
68.18%
Underperform Votes
42
31.82%

In the previous week, Hookipa Pharma had 4 more articles in the media than Immunic. MarketBeat recorded 6 mentions for Hookipa Pharma and 2 mentions for Immunic. Hookipa Pharma's average media sentiment score of 0.30 beat Immunic's score of 0.28 indicating that Hookipa Pharma is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hookipa Pharma
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Immunic
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Hookipa Pharma currently has a consensus target price of $5.50, indicating a potential upside of 364.14%. Immunic has a consensus target price of $17.75, indicating a potential upside of 992.31%. Given Immunic's stronger consensus rating and higher possible upside, analysts plainly believe Immunic is more favorable than Hookipa Pharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hookipa Pharma
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Immunic
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

Summary

Immunic beats Hookipa Pharma on 9 of the 17 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HOOK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HOOK vs. The Competition

MetricHookipa PharmaPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$65.39M$5.74B$4.48B$6.25B
Dividend YieldN/A2.61%6.01%6.50%
P/E Ratio-1.305.13101.4612.33
Price / Sales4.59323.133,443.9888.12
Price / CashN/A20.1522.1223.57
Price / Book0.644.784.665.44
Net Income-$64.92M$187.16M$116.24M$192.22M
7 Day Performance-2.05%4.01%3.31%2.69%
1 Month Performance-28.44%2.04%2.93%4.58%
1 Year Performance-29.71%19.10%13.23%1.19%

Hookipa Pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IMUX
Immunic
2.3584 of 5 stars
$1.74
+1.8%
$17.75
+920.1%
-53.4%$75.93MN/A-0.4855Positive News
VLON
Vallon Pharmaceuticals
0 of 5 stars
$5.59
-3.5%
N/A-63.3%$75.36M$100,000.00-7.173Gap Up
APLT
Applied Therapeutics
2.469 of 5 stars
$1.30
flat
$3.63
+178.8%
+9.8%$75.20M$10.66M-0.7634Positive News
IPA
ImmunoPrecise Antibodies
2.0259 of 5 stars
$3.02
+9.0%
$8.00
+165.3%
-43.6%$75.17M$15.32M-3.5973Positive News
RZLT
Rezolute
1.9961 of 5 stars
$2.09
-0.5%
$11.80
+464.6%
-27.0%$76.97MN/A-1.8726Positive News
SYRS
Syros Pharmaceuticals
2.1687 of 5 stars
$3.75
+1.4%
$15.75
+320.0%
-57.8%$77.25M$14.88M-0.39124
DMAC
DiaMedica Therapeutics
2.1862 of 5 stars
$2.82
+2.5%
$10.00
+254.6%
+9.2%$74.62MN/A-4.7814Positive News
Gap Up
CLNN
Clene
1.7469 of 5 stars
$0.95
+1.1%
$10.00
+953.9%
-58.6%$74.38M$470,000.00-2.4395
BLPH
Bellerophon Therapeutics
2.1272 of 5 stars
$7.06
-5.1%
$30.00
+324.9%
+606.0%$73.78MN/A-5.7921Analyst Downgrade
News Coverage
Gap Down
Trading Halted
SLGL
Sol-Gel Technologies
2.3516 of 5 stars
$3.40
-5.6%
$11.50
+238.2%
-42.4%$78.64M$3.88M-4.1565News Coverage
Positive News
Gap Down

Related Companies and Tools

This page (NASDAQ:HOOK) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -